173 related articles for article (PubMed ID: 37642472)
21. Pan-urologic cancer genomic subtypes that transcend tissue of origin.
Chen F; Zhang Y; Bossé D; Lalani AA; Hakimi AA; Hsieh JJ; Choueiri TK; Gibbons DL; Ittmann M; Creighton CJ
Nat Commun; 2017 Aug; 8(1):199. PubMed ID: 28775315
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and environmental factors in urologic cancer.
Morrison AS
Cancer; 1987 Aug; 60(3 Suppl):632-4. PubMed ID: 3594396
[TBL] [Abstract][Full Text] [Related]
23. Genomic Subtyping in Bladder Cancer.
Jalanko T; de Jong JJ; Gibb EA; Seiler R; Black PC
Curr Urol Rep; 2020 Mar; 21(2):9. PubMed ID: 32166460
[TBL] [Abstract][Full Text] [Related]
24. 3D Tumor Models in Urology.
Neuhaus J; Rabien A; Reinhold A; Koehler L; Berndt-Paetz M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047203
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic markers in urology].
Hupe MC; Hempel MC; Rodler S; Frantzi M; Mischak H; Merseburger AS; Stief CG; Chaloupka M
Urologe A; 2021 Oct; 60(10):1323-1330. PubMed ID: 34156515
[TBL] [Abstract][Full Text] [Related]
26. An update on the molecular pathology of urinary bladder tumors.
Yousef PG; Gabril MY
Pathol Res Pract; 2018 Jan; 214(1):1-6. PubMed ID: 29254798
[TBL] [Abstract][Full Text] [Related]
27. Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
Aveta A; Cilio S; Contieri R; Spena G; Napolitano L; Manfredi C; Franco A; Crocerossa F; Cerrato C; Ferro M; Del Giudice F; Verze P; Lasorsa F; Salonia A; Nair R; Walz J; Lucarelli G; Pandolfo SD
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446024
[TBL] [Abstract][Full Text] [Related]
28. [Molecular tumor board-urothelial cancer].
Hupe MC; Gakis G; Seiler R
Urologe A; 2019 Jul; 58(7):760-767. PubMed ID: 31172245
[TBL] [Abstract][Full Text] [Related]
29. Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.
Chekaluk Y; Wu CL; Rosenberg J; Riester M; Dai Q; Lin S; Guo Y; McDougal WS; Kwiatkowski DJ
PLoS One; 2013; 8(4):e60927. PubMed ID: 23593348
[TBL] [Abstract][Full Text] [Related]
30. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW; Alcaraz A; Bjartell AS; De Vere White R; Evans CP; Fussel S; Hamdy FC; Kallioniemi O; Mengual L; Schlomm T; Visakorpi T
Eur Urol; 2011 May; 59(5):671-81. PubMed ID: 21296484
[TBL] [Abstract][Full Text] [Related]
32. Extracellular Vesicles and Their Role in Urologic Malignancies.
Junker K; Heinzelmann J; Beckham C; Ochiya T; Jenster G
Eur Urol; 2016 Aug; 70(2):323-31. PubMed ID: 26924769
[TBL] [Abstract][Full Text] [Related]
33. Pathomics in urology.
Schuettfort VM; Pradere B; Rink M; Comperat E; Shariat SF
Curr Opin Urol; 2020 Nov; 30(6):823-831. PubMed ID: 32881725
[TBL] [Abstract][Full Text] [Related]
34. Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.
Bagrodia A; Cha EK; Sfakianos JP; Zabor EC; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA; Iyer G; Scott SN; Shah R; Ostrovnaya I; Lee B; Desai NB; Ren Q; Rosenberg JE; Dalbagni G; Bajorin DF; Reuter VE; Berger MF;
J Urol; 2016 Jun; 195(6):1684-1689. PubMed ID: 26778714
[TBL] [Abstract][Full Text] [Related]
35. Urological malignancies and the proteomic-genomic interface.
Unwin RD; Knowles MA; Selby PJ; Banks RE
Electrophoresis; 1999 Dec; 20(18):3629-37. PubMed ID: 10612290
[TBL] [Abstract][Full Text] [Related]
36. GSTM1, GSTT1 and GSTP1 Genetic Variants in Multiple Urologic Cancers.
Chirilă DN; Popp R; Vesa Ș; Bălăcescu O; Coman I; Constantea NA; Ciuce C;
Chirurgia (Bucur); 2015; 110(3):254-61. PubMed ID: 26158735
[TBL] [Abstract][Full Text] [Related]
37. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
38. Multiple primary cancers in urologic patients. Audit of 19-year experience in Berlin and review of the literature.
Wegner HE
Urology; 1992 Mar; 39(3):231-6. PubMed ID: 1546416
[TBL] [Abstract][Full Text] [Related]
39. Nucleic acid-based marker approaches to urologic cancers.
Veltri RW; Makarov DV
Urol Oncol; 2006; 24(6):510-27. PubMed ID: 17138133
[TBL] [Abstract][Full Text] [Related]
40. Detection and isolation of circulating tumor cells in urologic cancers: a review.
Loberg RD; Fridman Y; Pienta BA; Keller ET; McCauley LK; Taichman RS; Pienta KJ
Neoplasia; 2004; 6(4):302-9. PubMed ID: 15256052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
